Can low magnesium status and TRPM6 variation increase nervous-system excitability and impair sleep downshifting?

Magnesium is a critical regulator of central nervous system equilibrium, acting as a natural brake on excitatory pathways. Genetic variations in transport channels can alter this balance, directly impacting both neuromuscular tone and sleep architecture.

Mechanistic pathways of excitability and sleep

• NMDA and GABA regulation: Magnesium serves as a physiological blocker of NMDA glutamate receptors, limiting calcium influx. Low magnesium status removes this tonic blockade, resulting in glutamate-driven neuronal depolarization, heightened firing, and systemic hyperexcitability (manifesting as tremors, spasms, and anxiety).
• Sleep downshifting: Magnesium deficiency shifts the GABA-to-glutamate balance toward excitation, keeping cortisol levels elevated and disrupting melatonin synthesis. Clinical trials demonstrate that correcting magnesium depletion stabilizes the hypothalamic-pituitary-adrenal (HPA) axis, reduces sleep latency, and improves REM and deep sleep architecture.

Genetic modulation via TRPM6

• Systemic magnesium depletion: The TRPM6 channel regulates epithelial magnesium absorption in the gut and reabsorption in the kidneys. Severe loss-of-function mutations cause profound hypomagnesemia, leading to clinical seizures and tetany.
• Polymorphisms and dietary interaction: The common TRPM6 missense variant rs3750425 (Val1393Ile) reduces serum magnesium levels, an effect that is exacerbated when dietary magnesium intake is low. This genetic impairment lowers the threshold for neuronal firing by reducing the available magnesium pool.
• Sleep phenotypes: Although systemic magnesium depletion is clinically proven to impair sleep downshifting, direct clinical or polysomnographic data linking specific TRPM6 genotypes to sleep quality or insomnia phenotypes are currently unavailable.

Bottom line

• Low magnesium status and TRPM6 variations (such as rs3750425) compromise the physiological NMDA-receptor block, directly promoting nervous-system excitability. Correcting magnesium deficiency clinically reverses hyperarousal and sleep disruption, though direct studies have not yet mapped TRPM6 genotypes directly to sleep architecture.